Relmada Therapeutics, Inc. (RLMD) Social Stream
RELMADA THERAPEUTICS INC (RLMD) Price Targets From Analysts
Use the tables below to see what analysts covering RELMADA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 4 | $90 | $50 | $72.5 | $3.79 | 1812.93% |
| 2021-11-18 | 5 | $90 | $50 | $68 | $3.79 | 1694.2% |
| 2022-01-23 | 4 | $90 | $42 | $66.4 | $3.79 | 1651.98% |
| 2022-05-05 | 5 | $90 | $42 | $66.4 | $3.79 | 1651.98% |
| 2022-08-11 | 5 | $90 | $42 | $64.2 | $3.79 | 1593.93% |
| 2022-09-06 | 6 | $90 | $42 | $63.5 | $3.79 | 1575.46% |
| 2022-09-23 | 7 | $90 | $42 | $66 | $3.79 | 1641.42% |
| 2022-10-14 | 7 | $81 | $10 | $54.571 | $3.79 | 1339.87% |
| 2022-11-10 | 7 | $60 | $6.5 | $21.75 | $3.79 | 473.88% |
| 2023-03-24 | 5 | $60 | $6.5 | $21.125 | $3.79 | 457.39% |
| 2023-05-11 | 6 | $60 | $6.5 | $22.1 | $3.79 | 483.11% |
| 2023-08-08 | 6 | $60 | $3.5 | $21.5 | $3.79 | 467.28% |
| 2023-08-10 | 5 | $60 | $3.25 | $20.312 | $3.79 | 435.94% |
| 2023-11-08 | 4 | $10 | $3 | $5.416 | $3.79 | 42.9% |
The Trend in the Analyst Price Target
Over the past 30 months, RLMD's average price target has gone down $64.08.
RLMD reports an average of 488.63% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-15 | 6 | 60 | 3.50 | 21.500 | 2.55 | 743.14% |
| 2023-08-10 | 5 | 60 | 3.25 | 21.250 | 2.86 | 643.01% |
| 2023-08-10 | 6 | 10 | 3.00 | 5.416 | 2.86 | 89.37% |
| 2023-08-10 | 6 | 10 | 3.25 | 7.083 | 2.86 | 147.66% |
| 2023-08-10 | 4 | 60 | 3.25 | 20.312 | 2.86 | 610.21% |
RLMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 19 months, RLMD's average broker recommendation rating worsened by 1.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, RELMADA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2066.83% of them.
- In the context of all US stocks, RELMADA THERAPEUTICS INC's variance in analysts' estimates is lower than -1893.13% of them.
- RLMD has a greater average analyst price target than 1513.09% of stocks in the small market cap category.
- In the context of Healthcare stocks, RELMADA THERAPEUTICS INC's number of analysts covering the stock is greater than 657.44% of them.
In the Pharmaceutical Products industry, PDSB, EPIX, and VKTX are the three stocks most similar to RELMADA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for RLMD? Use POWR Ratings for clearer insight into price direction.